Effects of Long-Term, Medically Supervised, Drug-Free Treatment and Methadone Maintenance Treatment on Drug Users' Emergency Department Use and Hospitalization

Turner, Barbara J.; Laine, Christine; Yang, Chuya P.; Hauck, Walter W.
December 2003
Clinical Infectious Diseases;12/15/2003 Supplement 5, Vol. 37, pS457
Academic Journal
We examined the effect of drug treatment in 1996 on repeated ( 2) emergency department visits and hospitalization in 1997 in a cohort of New York State Medicaid-enrolled human immunodeficiency virus (HIV)- positive and HIV-negative drug users. In HIV-positive drug users, the adjusted odds of repeated emergency department visits were increased for those receiving no long-term treatment (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.04-2.75), whereas the adjusted odds for those receiving methadone treatment and those receiving drug-free treatment for ≥ 6 months did not differ. The adjusted odds of hospitalization in the HIV-positive group were higher for those receiving long-term methadone treatment (OR, 1.69; 95% CI, 1.14- 2.55) and for those receiving no long-term treatment (OR, 1.91; 95% CI, 1.29-2.88), compared with those receiving drug-free treatment. In the HIV-negative group, these associations were similar but weaker. For both HIV-positive and HIV-negative drug users, long-term drug-free treatment was at least as effective as long-term methadone treatment in reducing use of services indicative of poorer access to care and/or poorer health.


Related Articles

  • Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency. Rhoades, Howard M.; Creson, Dan; Elk, Ronith; Schmitz, Joy; Grabowski, John // American Journal of Public Health;Jan1998, Vol. 88 Issue 1, p34 

    Objectives. This study examined two major methadone treatment factors, visit frequency and methadone dose, posited to be important in reducing intravenous drug use and human immunodeficiency virus (HIV) transmission. Methods. One hundred fifty opiate- dependent subjects randomly assigned to four...

  • SELF-REPORT INTERVIEW DATA FOR A STUDY OF HIV-1 INFECTION AMONG INTRAVENOUS DRUG USERS: DESCRIPTION OF METHODS AND PRELIMINARY EVIDENCE ON VALIDITY. Anthony, James C.; Vlahov, David; Celentano, David D.; Menon, A. S.; Margolick, Joseph B.; Cohn, Sylvia; Nelson, Kenrad E.; Polk, B. Frank // Journal of Drug Issues;Fall91, Vol. 21 Issue 4, p739 

    This article presents a description and preliminary evidence on validity of self-report interview methods being used in a study of HIV-1 infection and AIDS among intravenous drug users (IVDUs). The study population includes 2,616 currently active IVDUs living in or near Baltimore City, Maryland...

  • High Seroprevalence of Bloodborne Viruses among Street-Recruited Injection Drug Users from Buenos Aires, Argentina. Weissenbacher, Mercedes; Rossi, Diana; Radulich, Graciela; Sosa-Estáni, Sergio; Vila, Marcelo; Vivas, Enrique; Avila, María M.; Cuchi, Paloma; Rey, Jorge; Peralta, Liliana Martinez // Clinical Infectious Diseases;12/15/2003 Supplement 5, Vol. 37, pS348 

    Injection drug use is the main mechanism of human immunodeficiency virus (HIV) transmission in Argentina (40% of reported AIDS cases in Argentina). This study was conducted among street-recruited injection drug users (IDUs) from Buenos Aires, with the aim of estimating seroprevalence and...

  • Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users. Clarke, Susan M.; Mulcahy, Fiona M.; Tjia, John; Reynolds, Helen E.; Gibbons, Sara E.; Barry, Michael G.; Back, David J. // Clinical Infectious Diseases;11/1/2001, Vol. 33 Issue 9, p1595 

    Focuses on the administration of nevirapine and methadone to HIV-infected injection drug users. Interaction between nonnucleoside reverse transcriptase inhibitors and methadone; Pharmacokinetic action of methadone; Magnitude of the interaction between methadone and nevirapine; Mechanism of...

  • The Types of Drug Used by HIV-Infected Injection Drug Users in a Multistate Aurveillance Project: Implications for Intervention. Diaz, Theresa; Chu, Susan Y.; Byers Jr., Robert H.; Hersh, Bradley S.; Conti, Lisa; Rietmeijer, Cornelis A.; Mokotoff, Eve; Fann, S. Alan; Boyd, Denise; Iglesias, Lucia; Checko, Patricia J.; Frederick, Margaret; Hermann, Pat; Herr, Mary; Samuel, Michael C. // American Journal of Public Health;Dec1994, Vol. 84 Issue 12, p1971 

    Objectives. This study sought to describe the drugs used by drug injectors infected with human immunodeficiency virus (HIV) and to determine factors associated with the primary injection drug used. Methods. A cross-section of persons 18 years of age or older reported with HIV or acquired...

  • Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. De la Fuente, Luis; Bravo, Maria José; Toro, Carlos; Brugal, M. Teresa; Barrio, Gregorio; Soriano, Vicente; Vallejo, Fernando; Ballesta, Rosario // Journal of Epidemiology & Community Health;Jun2006, Vol. 60 Issue 6, p537 

    Objectives: To evaluate changes in the prevalence of HIV infection among young heroin users in three Spanish cities, and their association with harm reduction programmes (HRPs). Methods: Two cross sectional studies. The 1995 study included 596 users; half were street recruited and half were...

  • Variables Influencing Condom Use among Intravenous Drug Users. Magura, Stephen; Shapiro, Janet L.; Siddiqi, Qudsia; Lipton, Douglas S. // American Journal of Public Health;Jan1990, Vol. 80 Issue 1, p82 

    Abstract: Correlates of condom use were identified using cross-sectional data from a convenience sample of 211 sexually active intravenous drug users enrolled in methadone maintenance in New York City. Sixty-eight percent did not use condoms at all in the previous month and only 11 percent used...

  • Lessons from the History of the Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Epidemic among Spanish Drug Injectors. De Ia Fuente, L.; Bravo, M. J.; Barrio, G.; Parras, F.; Suárez, M.; Rodés, A.; Noguer, I. // Clinical Infectious Diseases;12/15/2003 Supplement 5, Vol. 37, pS410 

    In Spain,∼ 10 years passed between the time when human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) harm-reduction programs should have been developed with sufficient coverage to have an optimum impact on public health (before the HIV/AIDS epidemic's explosion in...

  • Drug Use, Harm Reduction, and Health Policies in Argentina: Obstacles and New Perspectives. Inchaurraga, Silvia // Clinical Infectious Diseases;12/15/2003 Supplement 5, Vol. 37, pS366 

    High human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) incidence among injection drug users (IDUs) shows the failure of traditional health policies. The preference of IDUs for injected cocaine exposes them to high risks for contracting HIV because of the frequency of...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics